Ottawa – The National Women’s Health Research Initiative (NWHRI), a joint initiative between the Canadian Institutes of Health Research and Women and Gender Equality Canada, was announced as part of the 2021 federal budget to advance a coordinated research program that addresses under-researched and high-priority areas of women’s health and to ensure new evidence improves women’s, girls’, and gender-diverse people’s …
TORONTO- Moderna Canada announces the appointment of Roger-Ketcha Ngassam as the Manufacturing Site Head for its mRNA vaccine manufacturing facility. A seasoned leader with local roots and extensive international experience, Roger will oversee the planning, construction, and execution at Moderna’s Good Manufacturing Practice (GMP) site, currently under construction in Laval, Quebec. He will also lead the local team recruitment as …
Ottawa – The latest edition of the Patented Medicine Prices Review Board (PMPRB) Meds Pipeline Monitor reports that oncology continued to dominate the therapeutic mix of the drug pipeline in 2022, with cancer treatments representing nearly one third (30%) of medicines in all phases of clinical trials. Treatments for infectious diseases held the second largest share of the pipeline, at 15%, due …
